{"id":"W2013601613","doi":"10.1371/journal.pone.0121211","title":"Magnitude of the Benefit of Progression-Free Survival as a Potential Surrogate Marker in Phase 3 Trials Assessing Targeted Agents in Molecularly Selected Patients with Advanced Non-Small Cell Lung Cancer: Systematic Review","year":2015,"lang":"en","type":"review","venue":"PLoS ONE","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Eli Lilly Japan; Pfizer; Chugai Pharmaceutical; Taiho Pharmaceutical; AstraZeneca; Eli Lilly and Company","keywords":"Surrogate endpoint; Lung cancer; Medicine; Oncology; Clinical trial; Internal medicine; Intensive care medicine; Bioinformatics; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.03382464,0.001343617,0.01196904,0.006381505,0.0003597135,0.002667273,0.001453289,0.001786372,0.001680674],"category_scores_gemma":[0.1226609,0.001029161,0.01155879,0.007086185,0.001402502,0.002399466,0.001283507,0.001260864,0.0001775231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003318312,"about_ca_system_score_gemma":0.005043004,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00289095,"about_ca_topic_score_gemma":0.008473917,"domain_scores_codex":[0.9587583,0.02178356,0.01279278,0.002447858,0.003847955,0.0003695669],"domain_scores_gemma":[0.8153605,0.1516194,0.02477358,0.001930832,0.005506,0.0008096982],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.002955976,0.00001897364,0.005724515,0.8571854,0.1032543,0.00009974655,0.0001710295,0.0003385881,0.000333801,0.0002077339,0.000954686,0.0287553],"study_design_scores_gemma":[0.004724879,0.001111186,0.02487855,0.3551333,0.6011934,0.000530315,0.0002661376,0.0006394206,0.0005589916,0.0007738931,0.01009922,0.00009069034],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006571097,0.9908993,0.0005535458,0.0003307735,0.0001746945,0.0005702775,0.0005612817,0.00002061929,0.000318333],"genre_scores_gemma":[0.273869,0.7180791,0.002627902,0.001578212,0.0003775975,0.002379385,0.0008536598,0.00003587467,0.0001991824],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.988031,"threshold_uncertainty_score":0.1788839,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05132807077938279,"score_gpt":0.3827981638476881,"score_spread":0.3314700930683053,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}